tradingkey.logo
搜尋

Sonoma Pharmaceuticals Inc

SNOA
添加自選
1.210USD
0.0000.00%
收盤 07/02, 13:00美東報價延遲15分鐘
2.09M總市值
虧損本益比TTM

Sonoma Pharmaceuticals Inc

1.210
0.0000.00%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

+8.04%

1月

0.00%

6月

-66.76%

今年開始到現在

-66.76%

1年

-59.26%

關鍵數據
1.220今開
1.225最高
60.65K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
3.50%換手率
1.210昨收
1.190最低
62.86K成交額
虧損本益比靜
0.61市淨率
0.00%股息率 TTM
-24.70%ROA
6.92052週最高
0.42量比
-3.46M淨利潤
1.73M總股本
-1.9416每股盈餘TTM
1.29Beta
-81.19%ROE
0.85052週最低
2.89%振幅
39.22%毛利率
2.09M總市值
--回報/風險
4.46%風險率

TradingKey Sonoma Pharmaceuticals Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Sonoma Pharmaceuticals Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名126/157位。機構持股佔比非常高,近一月多位分析師給出公司評級為。最高目標價為14.80。中期看,股價處於下降通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Sonoma Pharmaceuticals Inc評分

相關信息

行業排名
126 / 157
全市場排名
433 / 4565
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Sonoma Pharmaceuticals Inc亮點

亮點風險
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
業績高增長
公司營業收入穩步增長,連續3年增長53.35%
業績增長期
公司處於發展階段,最新年度總收入19.53M美元
估值合理
公司最新PE估值-0.62,處於3年歷史合理位
機構減倉
最新機構持股127.80K股,環比減少21.35%

分析師目標

基於 0 分析師
--
評級
14.800
目標均價
+1198.25%
漲幅空間

Sonoma Pharmaceuticals Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Sonoma Pharmaceuticals Inc簡介

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
公司代碼SNOA
公司Sonoma Pharmaceuticals Inc
CEOTrombly (Amy)
網址https://sonomapharma.com/

常見問題

Sonoma Pharmaceuticals Inc(SNOA)的當前股價是多少?

Sonoma Pharmaceuticals Inc(SNOA)的當前股價是 1.21。

Sonoma Pharmaceuticals Inc 的股票代碼是什麼?

Sonoma Pharmaceuticals Inc的股票代碼是SNOA。

Sonoma Pharmaceuticals Inc股票的52週最高點是多少?

Sonoma Pharmaceuticals Inc股票的52週最高點是6.92。

Sonoma Pharmaceuticals Inc股票的52週最低點是多少?

Sonoma Pharmaceuticals Inc股票的52週最低點是0.85。

Sonoma Pharmaceuticals Inc的市值是多少?

Sonoma Pharmaceuticals Inc的市值是2.18M。

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是多少

Sonoma Pharmaceuticals Inc(SNOA)股票的每股收益(EPS TTM)是-1.89。